MUC1 and breast cancer: In addition, T cells reactive with an HLA-A2*0201 class I epitope overlapping the MUC1 signal sequence (M1.2 epitope) have been demonstrated in breast cancer patients with this HLA type (Brossart et al, 1999; Beckhove et al, 2004; Correa et al, 2005).